Our data provide strong evidence for a dose-dependent association between SLE-predisposing IL10 genotypes and corresponding mRNA and protein levels of IL-10, and identify one underlying molecular mechanism to explain previous findings of elevated IL-10 serum levels in SLE patients that positively correlated with increased disease activity. This evidence concerns the gene IL10 and systemic lupus erythematosus.